Wells JL - Search Results

1

High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.

Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ. Bartha R, et al. Among authors: wells jl. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):786-93. doi: 10.1016/j.pnpbp.2007.12.011. Epub 2007 Dec 23. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18252268 Clinical Trial.

2

A novel clinical pharmacy experience for third-year medical students.

Wells JL, Borrie MJ, Crilly R, Brymer CD, Hurwitz JS. Wells JL, et al. Can J Clin Pharmacol. 2002 Spring;9(1):7-16. Can J Clin Pharmacol. 2002. PMID: 11919641

3

State of the art in geriatric rehabilitation. Part I: review of frailty and comprehensive geriatric assessment.

Wells JL, Seabrook JA, Stolee P, Borrie MJ, Knoefel F. Wells JL, et al. Arch Phys Med Rehabil. 2003 Jun;84(6):890-7. doi: 10.1016/s0003-9993(02)04929-8. Arch Phys Med Rehabil. 2003. PMID: 12808544 Review.

4

State of the art in geriatric rehabilitation. Part II: clinical challenges.

Wells JL, Seabrook JA, Stolee P, Borrie MJ, Knoefel F. Wells JL, et al. Arch Phys Med Rehabil. 2003 Jun;84(6):898-903. doi: 10.1016/s0003-9993(02)04930-4. Arch Phys Med Rehabil. 2003. PMID: 12808545 Review.

5

Treatment effect size of memantine therapy in Alzheimer disease and vascular dementia.

Smith M, Wells J, Borrie M. Smith M, et al. Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3):133-7. doi: 10.1097/00002093-200607000-00002. Alzheimer Dis Assoc Disord. 2006. PMID: 16917181 Review.

6

Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R; Alzheimer's Disease Neuroimaging Initiative. Nestor SM, et al. Among authors: wells jl. Brain. 2008 Sep;131(Pt 9):2443-54. doi: 10.1093/brain/awn146. Epub 2008 Jul 11. Brain. 2008. PMID: 18669512 Free PMC article.

7

Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls.

Montero-Odasso M, Wells J, Borrie M. Montero-Odasso M, et al. J Am Geriatr Soc. 2009 Feb;57(2):359-60. doi: 10.1111/j.1532-5415.2009.02085.x. J Am Geriatr Soc. 2009. PMID: 19207156 Free PMC article. No abstract available.

8

Reduced hippocampal glutamate in Alzheimer disease.

Rupsingh R, Borrie M, Smith M, Wells JL, Bartha R. Rupsingh R, et al. Among authors: wells jl. Neurobiol Aging. 2011 May;32(5):802-10. doi: 10.1016/j.neurobiolaging.2009.05.002. Epub 2009 Jun 6. Neurobiol Aging. 2011. PMID: 19501936

9

Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial.

Montero-Odasso M, Wells JL, Borrie MJ, Speechley M. Montero-Odasso M, et al. Among authors: wells jl. BMC Neurol. 2009 Aug 12;9:42. doi: 10.1186/1471-2377-9-42. BMC Neurol. 2009. PMID: 19674471 Free PMC article. Clinical Trial.

10

Quantitative gait analysis under dual-task in older people with mild cognitive impairment: a reliability study.

Montero-Odasso M, Casas A, Hansen KT, Bilski P, Gutmanis I, Wells JL, Borrie MJ. Montero-Odasso M, et al. Among authors: wells jl. J Neuroeng Rehabil. 2009 Sep 21;6:35. doi: 10.1186/1743-0003-6-35. J Neuroeng Rehabil. 2009. PMID: 19772593 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters